Misses and near-misses after postoperative radiation therapy for head and neck cancer: Comparison of IMRT and non-IMRT techniques in the CT-simulation era

Head and Neck

Volumn 32, Issue 11, 2010, Pages 1452-1459

  Chen, Allen M ^a   Farwell, D Gregory ^a   Luu, Quang ^a   Chen, Leon M ^a   Vijayakumar, Srinivasan ^a   Purdy, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

head and neck cancer; intensity modulated radiotherapy; local regional recurrence; marginal miss; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SIMULATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOSIMETRY; FEMALE; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEAD AND NECK SURGERY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECK METASTASIS; OVERALL SURVIVAL; PAROTID GLAND; PHYSICIAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77956874781     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21343     Document Type: Article

References (25)

1. Mendenhall WM, Mancuso AA,. Radiotherapy for head and neck cancer-is the "next level" down? Int J Radiat Oncol Biol Phys 2009; 73: 645-646.
2. Harari PM,. Beware the swing and a miss: baseball precautions for conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 657-659.
3. Lee WR,. Technology assessment: vigilance required. Int J Radiat Oncol Biol Phys 2008; 70: 652-653.
4. Grégoire V, Eisbruch A, Hamoir M, Levendag P,. Proposal for the delineation of the nodal CTV in the node-positive and post-operative neck. Radiother Oncol 2006; 79: 15-20.
5. Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF,. Determining optimal clinical target volume in head and neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002; 53: 1174-1184.
6. Poon I, Fischbein N, Lee N, et al. A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys 2004; 59: 1301-1311.
7. Rasch C, Steenbakkers R, van Herk M,. Target definition in prostate, head, and neck. Semin Radiat Oncol 2005; 15: 136-145.
8. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000; 46: 1117-1126.
10. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004; 59: 28-42.
11. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA,. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 2003; 55: 312-321.
12. Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D,. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998; 41: 929-931.
13. Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC,. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 1999; 45: 33-39.
14. Som PM, Curtin HD, Mancuso AA,. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol 2000; 174: 837-844.
15. Wijers OB, Levendag PC, Tan T, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 1999; 52: 35-42.
16. Levendag P, Braaksma M, Coche E, et al. Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys 2004; 58: 113-123.
17. DAHANCA, EORTC, GORTEC, NCIC and RTOG endorsed consensus guidelines for the delineation of the CTV in the N0 neck of patients with head and neck squamous cell carcinoma. Accessed December 1, 2008.
18. Eisbruch A, Gregoire V,. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol 2009; 19: 43-52.
19. Cannon DM, Lee NY,. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 70: 660-665.
20. Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM,. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 71: 377-385.
21. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM,. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003; 57: 49-60.
22. Gomez DR, Zhung JE, Gomez J, et al. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2009; 73: 1096-1103.
23. Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 72: 747-755.
24. Purdy JA,. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys 2008; 95: 666-676.
25. Khuntia D, Harris J, Bentzen SM, et al. Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: preliminary results of RTOG 0234. Int J Radiat Oncol Biol Phys 2008; 72: S33.